Literature DB >> 31433987

Hantavirus Inhibits TRAIL-Mediated Killing of Infected Cells by Downregulating Death Receptor 5.

Carles Solà-Riera1, Shawon Gupta2, Kimia T Maleki1, Patricia González-Rodriguez3, Dalel Saidi3, Christine L Zimmer1, Sindhu Vangeti4, Laura Rivino5, Yee-Sin Leo6, David Chien Lye6, Paul A MacAry7, Clas Ahlm8, Anna Smed-Sörensen4, Bertrand Joseph3, Niklas K Björkström1, Hans-Gustaf Ljunggren1, Jonas Klingström9.   

Abstract

Cytotoxic lymphocytes normally kill virus-infected cells by apoptosis induction. Cytotoxic granule-dependent apoptosis induction engages the intrinsic apoptosis pathway, whereas death receptor (DR)-dependent apoptosis triggers the extrinsic apoptosis pathway. Hantaviruses, single-stranded RNA viruses of the order Bunyavirales, induce strong cytotoxic lymphocyte responses in infected humans. Cytotoxic lymphocytes, however, are largely incapable of eradicating hantavirus-infected cells. Here, we show that the prototypic hantavirus, Hantaan virus (HTNV), induces TRAIL production but strongly inhibits TRAIL-mediated extrinsic apoptosis induction in infected cells by downregulating DR5 cell surface expression. Mechanistic analyses revealed that HTNV triggers both 26S proteasome-dependent degradation of DR5 through direct ubiquitination of DR5 and hampers DR5 transport to the cell surface. These results corroborate earlier findings, demonstrating that hantavirus also inhibits cytotoxic cell granule-dependent apoptosis induction. Together, these findings show that HTNV counteracts intrinsic and extrinsic apoptosis induction pathways, providing a defense mechanism utilized by hantaviruses to inhibit cytotoxic cell-mediated eradication of infected cells.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MG132; RNA virus; TRAIL; apoptosis; death receptor 5; dengue virus; hantavirus; influenza; orthohantavirus; ubiquitin

Mesh:

Substances:

Year:  2019        PMID: 31433987     DOI: 10.1016/j.celrep.2019.07.066

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  5 in total

Review 1.  Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?

Authors:  Alison M Kell
Journal:  J Mol Biol       Date:  2021-09-04       Impact factor: 5.469

Review 2.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

3.  An ultrasensitive fiveplex activity assay for cellular kinases.

Authors:  Christian M Smolko; Kevin A Janes
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

4.  Hantavirus inhibits apoptosis by preventing mitochondrial membrane potential loss through up-regulation of the pro-survival factor BCL-2.

Authors:  Carles Solà-Riera; Marina García; Hans-Gustaf Ljunggren; Jonas Klingström
Journal:  PLoS Pathog       Date:  2020-02-07       Impact factor: 6.823

5.  Identification of Novel Antiviral Compounds Targeting Entry of Hantaviruses.

Authors:  Jennifer Mayor; Giulia Torriani; Olivier Engler; Sylvia Rothenberger
Journal:  Viruses       Date:  2021-04-16       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.